Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) EPS (Weighted Average and Diluted) (2016 - 2025)

Icu Medical (ICUI) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with -$0.63 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 35.05% year-over-year to -$0.63, compared with a TTM value of $0.03 through Dec 2025, up 100.62%, and an annual FY2025 reading of $0.03, up 100.62% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.63 for Q4 2025 at Icu Medical, down from -$0.14 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.43 in Q2 2025 and bottomed at -$1.63 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.22, with a median of -$0.48 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 550.0% in 2024, then soared 262.5% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.91 in 2021, then tumbled by 170.33% to -$0.64 in 2022, then decreased by 10.94% to -$0.71 in 2023, then crashed by 36.62% to -$0.97 in 2024, then soared by 35.05% to -$0.63 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ICUI at -$0.63 in Q4 2025, -$0.14 in Q3 2025, and $1.43 in Q2 2025.